Article Image
IPFS News Link • Vaccines and Vaccinations

A combined influenza and COVID-19 mRNA vaccine

• News Medical Life Sciences

The coronavirus disease 19 (COVID-19) pandemic, which was caused by the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has adversely impacted the health of people throughout the world. To date, over 584 million have been infected with SARS-CoV-2, of whom over 6.4 million have died.

The clinical symptoms of COVID-19 can range from cough, fever, and sore throat to mild or severe pneumonia and acute respiratory distress syndrome (ARDS).


The spread of other epidemic respiratory diseases during the cold season increases the risk of co-infections with two or more respiratory pathogens.

One of the most common respiratory pathogens is the influenza virus, which has previously been reported to co-infect with SARS-CoV-2. Both these viruses have similar transmission routes and cause comparable clinical symptoms after infection.